It has been found that blocking TRAF6 limits the inflammatory response-mediated by intracranial hemorrhage (Yang et al., 2020), Alzheimer’s disease (Wang et al., 2018), and Salmonella typhimurium infection (Min et al., 2017). This evidence concerns the gene TRAF6 and Alzheimer disease.